565 related articles for article (PubMed ID: 26576437)
1. Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus.
Hashemian SJ; Kouhnavard M; Nasli-Esfahani E
J Diabetes Res; 2015; 2015():675103. PubMed ID: 26576437
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
Vija L; Farge D; Gautier JF; Vexiau P; Dumitrache C; Bourgarit A; Verrecchia F; Larghero J
Diabetes Metab; 2009 Apr; 35(2):85-93. PubMed ID: 19230736
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus.
Domouky AM; Hegab AS; Al-Shahat A; Raafat N
Int J Biochem Cell Biol; 2017 Jun; 87():77-85. PubMed ID: 28385600
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cell-based therapy for the treatment of type 1 diabetes mellitus.
Mabed M; Shahin M
Curr Stem Cell Res Ther; 2012 May; 7(3):179-90. PubMed ID: 22023626
[TBL] [Abstract][Full Text] [Related]
5. Glucose-stimulated insulin secretion of various mesenchymal stem cells after insulin-producing cell differentiation.
Kim SJ; Choi YS; Ko ES; Lim SM; Lee CW; Kim DI
J Biosci Bioeng; 2012 Jun; 113(6):771-7. PubMed ID: 22425523
[TBL] [Abstract][Full Text] [Related]
6. Do we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells.
Sharma A; Rani R
Stem Cell Res Ther; 2017 Jul; 8(1):167. PubMed ID: 28701182
[TBL] [Abstract][Full Text] [Related]
7. Adipose tissue-derived mesenchymal stromal cells efficiently differentiate into insulin-producing cells in pancreatic islet microenvironment both in vitro and in vivo.
Karaoz E; Okcu A; Ünal ZS; Subasi C; Saglam O; Duruksu G
Cytotherapy; 2013 May; 15(5):557-70. PubMed ID: 23388582
[TBL] [Abstract][Full Text] [Related]
8. Transplantation of stem cells from umbilical cord blood as therapy for type I diabetes.
Stiner R; Alexander M; Liu G; Liao W; Liu Y; Yu J; Pone EJ; Zhao W; Lakey JRT
Cell Tissue Res; 2019 Nov; 378(2):155-162. PubMed ID: 31209568
[TBL] [Abstract][Full Text] [Related]
9. From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Progress and Challenges.
Ghoneim MA; Refaie AF; Elbassiouny BL; Gabr MM; Zakaria MM
Stem Cell Rev Rep; 2020 Dec; 16(6):1156-1172. PubMed ID: 32880857
[TBL] [Abstract][Full Text] [Related]
10. Human umbilical cord-derived mesenchymal stem cells can secrete insulin in vitro and in vivo.
Boroujeni ZN; Aleyasin A
Biotechnol Appl Biochem; 2014; 61(2):82-92. PubMed ID: 23725211
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells and type 1 diabetes treatment.
Boháčová P; Holáň V
Vnitr Lek; 2018; 64(7-8):725-728. PubMed ID: 30441979
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of PDX1 gene-modified human umbilical cord mesenchymal stem cells into insulin-producing cells in vitro.
He D; Wang J; Gao Y; Zhang Y
Int J Mol Med; 2011 Dec; 28(6):1019-24. PubMed ID: 21837359
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells in the treatment of type 1 diabetes mellitus.
Katuchova J; Harvanova D; Spakova T; Kalanin R; Farkas D; Durny P; Rosocha J; Radonak J; Petrovic D; Siniscalco D; Qi M; Novak M; Kruzliak P
Endocr Pathol; 2015 May; 26(2):95-103. PubMed ID: 25762503
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell therapy for diabetes through paracrine mechanisms.
Xu YX; Chen L; Wang R; Hou WK; Lin P; Sun L; Sun Y; Dong QY
Med Hypotheses; 2008 Sep; 71(3):390-3. PubMed ID: 18538944
[TBL] [Abstract][Full Text] [Related]
15. Obestatin can potentially differentiate Wharton's jelly mesenchymal stem cells into insulin-producing cells.
El-Asfar RK; Kamal MM; Abd El-Razek RS; El-Demerdash E; El-Mesallamy HO
Cell Tissue Res; 2018 Apr; 372(1):91-98. PubMed ID: 29159483
[TBL] [Abstract][Full Text] [Related]
16. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.
Yaochite JN; de Lima KW; Caliari-Oliveira C; Palma PV; Couri CE; Simões BP; Covas DT; Voltarelli JC; Oliveira MC; Donadi EA; Malmegrim KC
Stem Cell Res Ther; 2016 Jan; 7():14. PubMed ID: 26781648
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory and protective effects of adipose tissue-derived mesenchymal stem cells in an allograft islet composite transplantation for experimental autoimmune type 1 diabetes.
Mohammadi Ayenehdeh J; Niknam B; Rasouli S; Hashemi SM; Rahavi H; Rezaei N; Soleimani M; Liaeiha A; Niknam MH; Tajik N
Immunol Lett; 2017 Aug; 188():21-31. PubMed ID: 28506774
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of mesenchymal stem cells to insulin-producing cells and their impact on type 1 diabetic rats.
Neshati Z; Matin MM; Bahrami AR; Moghimi A
J Physiol Biochem; 2010 Jun; 66(2):181-7. PubMed ID: 20422338
[TBL] [Abstract][Full Text] [Related]
19. Intravenous Infusion of Human Adipose Tissue-Derived Mesenchymal Stem Cells to Treat Type 1 Diabetic Mellitus in Mice: An Evaluation of Grafted Cell Doses.
Dang LT; Bui AN; Le-Thanh Nguyen C; Truong NC; Bui AT; Kim NP; Truong KD; Van Pham P
Adv Exp Med Biol; 2018; 1083():145-156. PubMed ID: 29423674
[TBL] [Abstract][Full Text] [Related]
20. From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Immunological Considerations.
Refaie AF; Elbassiouny BL; Kloc M; Sabek OM; Khater SM; Ismail AM; Mohamed RH; Ghoneim MA
Front Immunol; 2021; 12():690623. PubMed ID: 34248981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
